Rani Therapeutics Reports Third Quarter 2024 Financial Results; Provides Corporate Update
November 14, 2024 08:00 ET
|
Rani Therapeutics, LLC
- Completed two equity offerings with total gross proceeds of approximately $20.0 million; cash runway extended into 3Q 2025 - - Announced new preclinical pharmacokinetic data supporting...
LXP Industrial Trust to Report Third Quarter 2024 Results and Host Conference Call November 6, 2024
October 08, 2024 07:00 ET
|
LXP Industrial Trust
WEST PALM BEACH, Fla., Oct. 08, 2024 (GLOBE NEWSWIRE) -- LXP Industrial Trust (NYSE: LXP) (“LXP”), a real estate investment trust (REIT) focused on Class A warehouse and distribution real estate...
Progress Announces Third Quarter 2024 Financial Results
September 24, 2024 16:15 ET
|
Progress Software Corporation
Progress announces third quarter financial earnings for fiscal year 2024
Rani Therapeutics Reports Third Quarter 2023 Financial Results; Provides Corporate Update
November 08, 2023 16:05 ET
|
Rani Therapeutics, LLC
- Cash runway extended into 2025 - - Announced strategic program prioritization, expansion of manufacturing and plans to streamline business operations - - Initiated Phase 1 clinical trial of...
Rani Therapeutics Announces Strategic Program Prioritization, Expansion of Manufacturing and Plans to Streamline Business Operations to Support Near-Term Value Drivers and Long-Term Growth of the RaniPill® Technology Platform; Reports Preliminary Third Quarter 2023 Financial Results
November 01, 2023 16:05 ET
|
Rani Therapeutics, LLC
- Cash runway extended into 2025 - - Cash runway expected to extend beyond topline results from Phase 2 trial for RT-102, topline results from Phase 1 trial for RT-111, and development of...